Hütter-Krönke, M. L., Fiedler, W., Kündgen, A., Krauter, J., von Lilienfeld-Toal, M., Döhner, H. and Schlenk, R. F. (2019) “Continuous high dosing of lenalidomide in relapsed, refractory or older newly diagnosed acute myeloid leukemia patients not suitable for other treatment options - results from a phase I study”, Haematologica. Pavia, Italy, 104(2), pp. e63-e64. doi: 10.3324/haematol.2018.199794.